An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β-Reference-Cited by-同舟云学术

An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

Published:2015-06-24 Issue:6 Volume:14 Page:804-810
ISSN:1871-5273
Container-title:CNS & Neurological Disorders - Drug Targets
language:en
Short-container-title:CNSNDDT

Author:

Balasa Rodica,Maier Smaranda,Voidazan Septimiu,Hutanu Adina,Bajko Zoltan,Motataianu Anca

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Neuroscience

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2020-04

2. INTERFERON-β 1A, AN IMMUNOMODULATOR IN RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS. THE EFFECT ON PRO-INFLAMMATORY CYTOKINES;FARMACIA;2020-02-25

3. The direct deleterious effect of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation and neurodegeneration;Revista Romana de Medicina de Laborator;2020-01-01

4. Effect of Interferon-Beta Treatment on the Proportion of T Helper 17 Cells and Related Cytokines in Multiple Sclerosis: A Meta-Analysis;Journal of Interferon & Cytokine Research;2019-12-01

5. Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis;Scandinavian Journal of Clinical and Laboratory Investigation;2017-03-20